×
About 73,958 results

ALLMedicine™ Cardiomyopathy Center

Research & Reviews  35,887 results

Young and early-onset dilated cardiomyopathy with malignant ventricular arrhythmia and ...
https://doi.org/10.1111/anec.12840
Annals of Noninvasive Electrocardiology : the Official Jo... Zhao T, Ma Y et. al.

May 5th, 2021 - The whole exome sequencing (WES) with targeted gene analysis is an effective diagnostic tool for cardiomyopathy. The early-onset sudden cardiac death (SCD) was commonly associated with dilated cardiomyopathy (DCM) induced by pathogenic genetic mut...

Cardiovascular disease among pregnant women after anticancer therapy.
https://doi.org/10.1111/jog.14812
The Journal of Obstetrics and Gynaecology Research; Aoki-Kamiya C, Shioyama W et. al.

May 5th, 2021 - Recent advances in cancer therapies have enabled many women diagnosed with malignancies during childhood and adolescence to survive longer and therefore to reach an age where they wish to conceive. When providing cancer treatment such as anticance...

An Evidence-Based Assessment of Genes in Dilated Cardiomyopathy.
https://doi.org/10.1161/CIRCULATIONAHA.120.053033
Circulation Jordan E, Peterson L et. al.

May 5th, 2021 - Background: The cardiomyopathies, classically categorized as hypertrophic (HCM), dilated (DCM), and arrhythmogenic right ventricular (ARVC), each have a signature genetic theme. HCM and ARVC are largely understood as genetic diseases of sarcomere ...

Phenotypic Recapitulation and Correction of Desmoglein-2-deficient Cardiomyopathy using...
https://doi.org/10.1093/hmg/ddab127
Human Molecular Genetics; Shiba M, Higo S et. al.

May 5th, 2021 - Desmoglein-2, encoded by DSG2, is one of the desmosome proteins that maintains the structural integrity of tissues, including heart. Genetic mutations in DSG2 cause arrhythmogenic cardiomyopathy, mainly in an autosomal dominant manner. Here, we id...

Childhood onset nexilin dilated cardiomyopathy: A heterozygous and a homozygous case.
https://doi.org/10.1002/ajmg.a.62231
American Journal of Medical Genetics. Part A; Bruyndonckx L, Vogelzang JL et. al.

May 5th, 2021 - Pathogenic heterozygous NEXN variants are associated with progressive dilated cardiomyopathy (DCM) usually presenting around 50 years of age. We describe an asymptomatic boy who had transient DCM at 3 months of age, that resolved by 4 months. Pres...

see more →

Guidelines  55 results

2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic ca...
https://doi.org/10.1016/j.jtcvs.2021.04.001
The Journal of Thoracic and Cardiovascular Surgery; , Ommen SR et. al.

Apr 30th, 2021 - 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.|2021| ,Ommen SR,Mital S...

ACR Appropriateness Criteria® Nonischemic Myocardial Disease with Clinical Manifestatio...
https://doi.org/10.1016/j.jacr.2021.01.019
Journal of the American College of Radiology : JACR; , Rajiah P et. al.

Mar 2nd, 2021 - Nonischemic cardiomyopathies encompass a broad spectrum of myocardial disorders with mechanical or electrical dysfunction without evidence of ischemia. There are five broad variants of nonischemic cardiomyopathies; hypertrophic cardiomyopathy (Var...

Minimally Invasive Bilateral Stellate Ganglionectomy for Refractory Ventricular Tachyca...
https://doi.org/10.1016/j.jacep.2020.12.001
JACC. Clinical Electrophysiology; Elliott IA, DeJesus M et. al.

Jan 9th, 2021 - Cardiac sympathetic denervation (CSD) for refractory ventricular tachycardia (VT) has been shown to decrease VT recurrence and defibrillator shocks in patients with ischemic and nonischemic cardiomyopathy. Here and in the accompanying Video, we de...

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Ca...
https://doi.org/10.1016/j.jacc.2020.08.045
Journal of the American College of Cardiology; Ommen SR, Mital S et. al.

Nov 24th, 2020 - 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.|2020|Ommen SR,Mital S,B...

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Ca...
https://doi.org/10.1016/j.jacc.2020.08.044
Journal of the American College of Cardiology; Ommen SR, Mital S et. al.

Nov 24th, 2020 - This executive summary of the hypertrophic cardiomyopathy clinical practice guideline provides recommendations and algorithms for clinicians to diagnose and manage hypertrophic cardiomyopathy in adult and pediatric patients as well as supporting d...

see more →

Drugs  49 results see all →

Clinicaltrials.gov  36,811 results

Young and early-onset dilated cardiomyopathy with malignant ventricular arrhythmia and ...
https://doi.org/10.1111/anec.12840
Annals of Noninvasive Electrocardiology : the Official Jo... Zhao T, Ma Y et. al.

May 5th, 2021 - The whole exome sequencing (WES) with targeted gene analysis is an effective diagnostic tool for cardiomyopathy. The early-onset sudden cardiac death (SCD) was commonly associated with dilated cardiomyopathy (DCM) induced by pathogenic genetic mut...

Cardiovascular disease among pregnant women after anticancer therapy.
https://doi.org/10.1111/jog.14812
The Journal of Obstetrics and Gynaecology Research; Aoki-Kamiya C, Shioyama W et. al.

May 5th, 2021 - Recent advances in cancer therapies have enabled many women diagnosed with malignancies during childhood and adolescence to survive longer and therefore to reach an age where they wish to conceive. When providing cancer treatment such as anticance...

An Evidence-Based Assessment of Genes in Dilated Cardiomyopathy.
https://doi.org/10.1161/CIRCULATIONAHA.120.053033
Circulation Jordan E, Peterson L et. al.

May 5th, 2021 - Background: The cardiomyopathies, classically categorized as hypertrophic (HCM), dilated (DCM), and arrhythmogenic right ventricular (ARVC), each have a signature genetic theme. HCM and ARVC are largely understood as genetic diseases of sarcomere ...

Phenotypic Recapitulation and Correction of Desmoglein-2-deficient Cardiomyopathy using...
https://doi.org/10.1093/hmg/ddab127
Human Molecular Genetics; Shiba M, Higo S et. al.

May 5th, 2021 - Desmoglein-2, encoded by DSG2, is one of the desmosome proteins that maintains the structural integrity of tissues, including heart. Genetic mutations in DSG2 cause arrhythmogenic cardiomyopathy, mainly in an autosomal dominant manner. Here, we id...

Childhood onset nexilin dilated cardiomyopathy: A heterozygous and a homozygous case.
https://doi.org/10.1002/ajmg.a.62231
American Journal of Medical Genetics. Part A; Bruyndonckx L, Vogelzang JL et. al.

May 5th, 2021 - Pathogenic heterozygous NEXN variants are associated with progressive dilated cardiomyopathy (DCM) usually presenting around 50 years of age. We describe an asymptomatic boy who had transient DCM at 3 months of age, that resolved by 4 months. Pres...

see more →

News  1,063 results

T1DM Confers Greater Risk of HF in Women than Men
https://www.medscape.com/viewarticle/950164

Apr 28th, 2021 - Takeaway Women with diabetes, especially those with type 1 diabetes mellitus (T1DM), had an increased risk of heart failure (HF) than men with diabetes. The increased risk cannot be explained solely by the higher prevalence of coronary artery dise...

ECG Challenge: Hypotension in a Cardiomyopathy Patient
https://www.medscape.com/viewarticle/947347

Mar 22nd, 2021 - A 69-year-old woman with a history of nonischemic cardiomyopathy — treated with a beta-blocker, angiotensin-converting enzyme inhibitor, and spironolactone — presents with worsening shortness of breath and hypotension. A chest x-ray demonstrates p...

Doctors Search for Missing Link Between COVID and ITP
https://www.medscape.com/viewarticle/944801

Jan 26th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Hospitalist Sarah Stone, MD, arrived for her dayshift at Sharp Chula Vista in California one day in late December. The ICU and hospital wards were...

STICH: Ischemia Not Linked to 10-Year Mortality, CABG Benefit
https://www.medscape.com/viewarticle/944555

Jan 21st, 2021 - The presence of ischemia on stress testing should not be used to refer patients with ischemic cardiomyopathy for coronary artery bypass graft (CABG) surgery, a new STICH analysis concludes. Previously, the Surgical Treatment for Ischemic Heart Fai...

New HCM Guidelines Make Shared Decision-making Top Priority
https://www.medscape.com/viewarticle/941365

Nov 19th, 2020 - Greater involvement of the patient and family in decision-making, clarity on the role of genetic testing and parameters for team-oriented care, and use of high-volume specialty centers are cornerstones of the first update in almost a decade of the...

see more →

Patient Education  93 results see all →